Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue
2022; Wiley; Volume: 52; Issue: 7 Linguagem: Inglês
10.1111/eci.13779
ISSN1365-2362
AutoresMatteo Lambertini, Camilla Marrocco, Stefano Spinaci, Isabelle Demeestere, Richard A. Anderson,
Tópico(s)Reproductive Biology and Fertility
ResumoEuropean Journal of Clinical InvestigationEarly View e13779 EDITORIAL Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue Matteo Lambertini, Corresponding Author Matteo Lambertini matteo.lambertini@unige.it orcid.org/0000-0003-1797-5296 Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy Correspondence Matteo Lambertini, IRCCS Ospedale Policlinico San Martino, University of Genova, Largo Rosanna Benzi 10, 16132 – Genova, Italy. Email: matteo.lambertini@unige.itSearch for more papers by this authorCamilla Marrocco, Camilla Marrocco Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, ItalySearch for more papers by this authorStefano Spinaci, Stefano Spinaci Division of Breast Surgery, Ospedale Villa Scassi, Genova, ItalySearch for more papers by this authorIsabelle Demeestere, Isabelle Demeestere Fertility clinic, CUB-Erasme Hospital, Université Libre de Bruxelles (U.L.B.), Brussels, BelgiumSearch for more papers by this authorRichard A. Anderson, Richard A. Anderson MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UKSearch for more papers by this author Matteo Lambertini, Corresponding Author Matteo Lambertini matteo.lambertini@unige.it orcid.org/0000-0003-1797-5296 Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy Correspondence Matteo Lambertini, IRCCS Ospedale Policlinico San Martino, University of Genova, Largo Rosanna Benzi 10, 16132 – Genova, Italy. Email: matteo.lambertini@unige.itSearch for more papers by this authorCamilla Marrocco, Camilla Marrocco Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, ItalySearch for more papers by this authorStefano Spinaci, Stefano Spinaci Division of Breast Surgery, Ospedale Villa Scassi, Genova, ItalySearch for more papers by this authorIsabelle Demeestere, Isabelle Demeestere Fertility clinic, CUB-Erasme Hospital, Université Libre de Bruxelles (U.L.B.), Brussels, BelgiumSearch for more papers by this authorRichard A. Anderson, Richard A. Anderson MRC Centre for Reproductive Health, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UKSearch for more papers by this author First published: 28 March 2022 https://doi.org/10.1111/eci.13779Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issuee13779 RelatedInformation
Referência(s)